VF
PRME icon

Virtu Financial’s Prime Medicine PRME Stock Holding History

Virtu Financial’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-94,778
Closed -$329K – 2162
2025
Q4 		$329K Buy
94,778
+82,948
+701% +$369K 0.01% 807
2025
Q3 		$66K Sell
11,830
-715
-6% -$2.9K ﹤0.01% 1098
2025
Q2 		$31K Buy
+12,545
New +$19.3K ﹤0.01% 1205
2024
Q3 		– Sell
-42,741
Closed -$220K – 1778
2024
Q2 		$220K Buy
+42,741
New +$259K 0.02% 673
2023
Q4 		– Sell
-12,466
Closed -$119K – 1911
2023
Q3 		$119K Buy
+12,466
New +$162K 0.01% 793

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Virtu Financial's PRME Position: Q1 2026 in Review

Virtu Financial sold out of Prime Medicine (PRME) in Q1 2026, closing a stake of 94,778 shares — an estimated $329K sold.

Virtu Financial first reported a position in PRME in Q3 2023 and held it in 5 quarters. The position peaked at $329K in Q4 2025. 192 funds tracked by Wall St. Rank hold PRME as of Q1 2026.

  • Virtu Financial reported no remaining Prime Medicine position as of Q1 2026 after selling out during the quarter.
  • Virtu Financial sold 94,778 Prime Medicine shares in Q1 2026, an estimated $329K.
  • Virtu Financial first reported a position in Prime Medicine in Q3 2023 and held it in 5 quarters.
  • Virtu Financial's Prime Medicine position peaked at $329K in Q4 2025.
  • 192 funds tracked by Wall St. Rank held Prime Medicine as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.